Overview

Safety and Efficacy of Saxagliptin Plus Insulin With or Without Metformin

Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effects of saxagliptin with those of placebo as add-on therapy to insulin and insulin with metformin in improving glycemic control at 24 and 52 weeks.
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Treatments:
Insulin
Insulin, Globin Zinc
Metformin
Saxagliptin